MARSHALL WACE, LLP - ATARA BIOTHERAPEUTICS INC ownership

ATARA BIOTHERAPEUTICS INC's ticker is ATRA and the CUSIP is 046513107. A total of 119 filers reported holding ATARA BIOTHERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.24 and the average weighting 0.1%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of ATARA BIOTHERAPEUTICS INC
ValueSharesWeighting
Q2 2023$100,109
-65.5%
62,180
-18.8%
0.00%
-100.0%
Q3 2022$290,000
-73.5%
76,606
+0.4%
0.00%
-80.0%
Q1 2021$1,096,000
-91.2%
76,274
-87.9%
0.01%
-92.5%
Q4 2020$12,420,000
+248.9%
632,743
+130.4%
0.07%
+191.3%
Q3 2020$3,560,000
-68.3%
274,670
-64.4%
0.02%
-70.9%
Q2 2020$11,248,000
+1880.3%
771,966
+5295.3%
0.08%
+2533.3%
Q1 2019$568,00014,3080.00%
Other shareholders
ATARA BIOTHERAPEUTICS INC shareholders Q2 2019
NameSharesValueWeighting ↓
Antipodean Advisors LLC 800,000$11,656,0005.38%
Consonance Capital Management LP 5,238,218$76,321,0004.57%
BRIDGER MANAGEMENT, LLC 1,785,784$26,019,0002.41%
Trellus Management Company, LLC 150,000$2,186,0002.37%
MAVERICK CAPITAL LTD 6,754,102$98,407,0002.07%
Redmile Group, LLC 6,843,370$99,708,0001.84%
Baupost Group 9,922,030$144,564,0001.80%
Camber Capital Management LP 1,400,000$20,398,0001.17%
Pinz Capital Management, LP 161,100$2,347,0001.08%
Artal Group S.A. 2,500,000$36,425,0001.02%
View complete list of ATARA BIOTHERAPEUTICS INC shareholders